Blood clots launch investigation over J&J vaccine
The Johnson & Johnson (J&J) COVID-19 vaccine is under investigation following the reports of rare (potentially dangerous) blood clots with leading pharmaceutical authorities recommending a delay in use. The Food and Drug Administration (FDA) released a joint statement with the U.S. Centers for Disease Control and Prevention (CDC) to “pause” the use of the Johnson & Johnson single-dose vaccine as they review the data of six cases of a severe and rare type of blood clot shortly after receiving the vaccine.
The recommended pause of Johnson & Johnson's vaccine, which makes up less than 5% of the recorded shots in arms in the U.S. to date, was “out of an abundance of caution,” says White House Covid-19 coordinator Jeff Zients https://t.co/IZjVQ8catD
— The Wall Street Journal (@WSJ) April 13, 2021
The six cases occurred among women patients between the ages of 18 and 48 with symptoms occurring 6 to 13 days after vaccination. These occurrences appear to be “extremely rare” while advising recipients of the J&J vaccine who experience symptoms including shortness of breath, severe headache, leg pain, or abdominal pain within three weeks of receiving the vaccine should contact their health care provider.
The White House will also be intervening in the growing issue with the J&J vaccine with the White House COVID-19 coordinator, Jeff Zients, working with federal and state partners to reschedule J&J vaccine patients to receive a Moderna or Pfizer vaccine. Johnson & Johnson disclosed in a statement they are aware of an extremely rare disorder including people with blood clots combined with low platelets in a small group of vaccine recipients.
The Biden administration is working with states to reschedule appointments for individuals who were in line to receive shots of Johnson & Johnson’s COVID-19 vaccine in the coming days. https://t.co/IRDEc9OPxt
— Michael Wilner (@mawilner) April 13, 2021
J&J maintains they’re working closely with health authorities and medical experts while supporting the open communication of this information to the public and health care professionals. J&J will also be reviewing potential cases with European health authorities and committed to proactively delay the rollout of the vaccine in Europe.
The Oxford-AstraZeneca vaccine is also experiencing similar concerns over rare blood clots with vaccines administered through the U.K., European Union (EU), and many other countries. Last week, the EU drug regulator said the benefits of the Oxford-AstraZeneca COVID-19 vaccine outweigh its risks.
Serena Williams Signs Docuseries Deal With Amazon
-
Devastating Loss of Lives Sparks Outrage and International Concern A devastating Russian attack on the peaceful village of Hroza,...
-
Dutch Research Organization’s Forecast Faces Skepticism from Scientists and Authorities Recent predictions by the Solar System Geometry Survey (SSGS),...
-
Rishi Sunak Explores Policies to Safeguard the Next Generation from Tobacco Harm British Prime Minister Rishi Sunak is contemplating...
-
Saudi Arabia Advocates Independent Palestinian State as Key to Peace The Saudi Foreign Minister, Faisal bin Farhan, reiterated Saudi...
-
Justin Trudeau Calls for Answers in the Hardeep Singh Nijjar Case Canadian Prime Minister Justin Trudeau has issued a...
-
Disaster Unfolds as Historic Rainfall Devastates Derna, Prompting Global Support Efforts An unprecedented disaster has struck northeastern Libya as...
-
Two-week manhunt ends as fugitive Danelo Souza Cavalcante is apprehended Danelo Souza Cavalcante, a convicted murderer who had been...
-
House Republicans Launch Formal Impeachment Inquiry into President Biden The US House of Representatives has announced the initiation of...
-
International Support Pours In as Morocco Grapples with Tremendous Loss and Injuries Tragedy has struck the picturesque region of...
-
Tensions Rise as the U.S. Takes Action Against Violations of Sanctions and International Law in the Gulf The United...
-
Palestinians continue to live under apartheid regime Recent reports have highlighted growing concerns over the accountability for the deaths...
-
India is on the moon! India’s space agency, the Indian Space Research Organisation (ISRO), has marked a remarkable milestone...